No Picture
Drug Development

STAT+: Obesity drug from Viking Therapeutics hits target in Phase 2 study, raising hopes for a competitor to existing medicines

An obesity drug from Viking Therapeutics succeeded in a Phase 2 study, helping patients lose nearly 15% of weight and further fueling the competition in the obesity market.  Click here to view original post Click […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Drug Development

STAT+: Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug in small study

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks […]

No Picture
Drug Development

STAT+: Differences in countries’ regulations keep some cell and gene therapies from reaching patients

CARLSBAD, Calif. — Biotech companies developing cutting-edge cell and gene therapies often are tripped up by how much regulations around these drugs vary from country to country. On Wednesday, regulators from the United States, the […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Drug Development

Perspective from a Scripps Research Graduate: Five Reasons You Should Be Attending DIA 2019 June 23-27 in San Diego

Guest Author: Sudip Parikh, Senior Vice President & Managing Director, Americas at DIA Global* I had a great experience as a Scripps Research graduate student in La Jolla. After graduating, I moved to the east […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Drug Development

SDBN March 26th 2012 Event with Organovo

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Biotechnology

Flip This Asset: San Diego’s Advanced BioHealing ‘Fixed Up’ Dermagraft for Profit and Growth #BIO2010

Wednesday I attended a regenerative medicine-focused breakfast at the BIO convention and learned about San Diego company Advanced BioHealing (ABH), who took a ‘fallen’ asset, Dermagraft, and not only turned it into an $85M/year product, […]